Document Classification

Section Type: RESULTS

Text: The use of SES was associated with a significantly lower incidence of the clinical endpoint (12. 6 % vs. 33. 1 % ; HR 0. 30, 95 % CI : 0. 17-0. 55 ; P < 0. 0001), which was not only due to a reduction in TLR (7. 9 % vs. 29. 9 % ; HR 0. 30, 95 % CI : 0. 16-0. 59 ; P < 0. 0001), but also to a reduction in myocardial infarction (1. 6 % vs. 10. 2 % ; HR 0. 09, 95 % CI : 0. 01-0. 66 ; P = 0. 018).